Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This trial aims to compare transtympanic steroids against the standard treatment
(transtympanic gentamicin) in refractory unilateral Meniere's disease.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Imperial College London
Collaborators:
Imperial College Healthcare NHS Trust Medical Research Council